Maryland Code § CS-9-603

Section CS-9-603
Open in Lexace · Ask the AI about this section
(a) (1) Subject to paragraph (2) of this subsection, the requirements
under this section shall apply to:
(i) local detention centers in the following counties by January
1, 2020:
1. Howard County;
2. Montgomery County;
3. Prince George's County; and
4. St. Mary's County; and
(ii) local detention centers in six additional counties by
October 1, 2021.
(2) (i) The Governor's Office of Crime Prevention and Policy, the
Maryland Department of Health, and the Maryland Correctional Administrators
Association shall evaluate the implementation of the requirements of this section and
determine a schedule to add additional counties, provided that the provisions of this
section shall apply to all local detention centers and the Baltimore Pre-trial Complex
by January 2023.
(ii) If the Baltimore Pre-trial Complex has not fully
implemented the provisions of this section by January 2023, the Department of Public
Safety and Correctional Services shall report to the Senate Finance Committee and
the House Judiciary Committee, in accordance with § 2-1257 of the State
Government Article, on the status and timeline of implementation.
(iii) Funding for the program at the Baltimore Pre-trial
Complex shall be as provided in the State budget.
(b) (1) In this section the following words have the meanings indicated.
(2) "Health care practitioner" means an individual who is licensed,
certified, or otherwise authorized to practice under the Health Occupations Article.
(3) "Incarcerated individual" means an individual confined within a
local correctional facility.
(4) "Medication" means a medication approved by the federal Food
and Drug Administration for the treatment of opioid use disorder.

(5) "Medication-assisted treatment" means the use of medication, in
combination with counseling and behavioral health therapies, to provide a holistic
approach to the treatment of opioid use disorder.
(6) "Opioid use disorder" means a medically diagnosed problematic
pattern of opioid use that causes significant impairment or distress.
(7) "Peer recovery specialist" means an individual who has been
certified by an entity approved by the Maryland Department of Health for the
purpose of providing peer support services, as defined under § 7.5-101(n) of the
Health - General Article.
(c) An incarcerated individual in a State or local correctional facility shall
be placed on a properly supervised program of methadone detoxification if:
(1) a physician determines that the incarcerated individual is a
person with an opioid use disorder;
(2) the treatment is prescribed by a physician; and
(3) the incarcerated individual consents in writing to the treatment.
(d) (1) Each local correctional facility shall conduct an assessment of the
mental health and substance use status of each incarcerated individual using
evidence-based screenings and assessments, to determine:
(i) if the medical diagnosis of an opioid use disorder is
appropriate; and
(ii) if medication-assisted treatment is appropriate.
(2) If an assessment conducted under paragraph (1) of this
subsection indicates opioid use disorder, an evaluation of the incarcerated individual
shall be conducted by a health care practitioner with prescriptive authority
authorized under Title 8, Title 14, or Title 15 of the Health Occupations Article.
(3) Information shall be provided to the incarcerated individual
describing medication options used in medication-assisted treatment.
(4) Medication-assisted treatment shall be available to an
incarcerated individual for whom such treatment is determined to be appropriate
under this subsection.

(5) Each local correctional facility shall make available at least one
formulation of each FDA-approved full opioid agonist, partial opioid agonist, and
long-acting opioid antagonist used for the treatment of opioid use disorders.
(6) Each pregnant woman identified with an opioid use disorder shall
receive evaluation and be offered medication-assisted treatment as soon as
practicable.
(e) Each local correctional facility shall:
(1) following an assessment using clinical guidelines for medication-
assisted treatment:
(i) make medication available by a qualified provider to the
incarcerated individual; or
(ii) begin withdrawal management services prior to
administration of medication;
(2) make available and administer medications for the treatment of
opioid use disorder;
(3) provide behavioral health counseling for incarcerated individuals
diagnosed with opioid use disorder consistent with therapeutic standards for such
therapies in a community setting;
(4) provide access to a health care practitioner who can provide
access to all FDA-approved medications for the treatment of opioid use disorders;
and
(5) provide on-premises access to peer recovery specialists.
(f) If an incarcerated individual received medication or medication-
assisted treatment for opioid use disorder immediately preceding or during the
incarcerated individual's incarceration, a local correctional facility shall continue the
treatment after incarceration or transfer unless:
(1) the incarcerated individual voluntarily discontinues the
treatment, verified through a written agreement that includes a signature; or
(2) a health care practitioner determines that the treatment is no
longer medically appropriate.

(g) Before the release of an incarcerated individual diagnosed with opioid
use disorder under subsection (d) of this section, a local correctional facility shall
develop a plan of reentry that:
(1) includes information regarding postincarceration access to
medication continuity, peer recovery specialists, other supportive therapy, and
enrollment in health insurance plans;
(2) includes any recommended referrals by a health care practitioner
to medication continuity, peer recovery specialists, and other supportive therapy; and
(3) is reviewed and, if needed, revised by a health care practitioner
or peer recovery specialist.
(h) The procedures and standards used to determine substance use disorder
diagnosis and treatment of incarcerated individuals are subject to the guidelines and
regulations adopted by the Maryland Department of Health.
(i) As provided in the State budget, the State shall fund the program of
opioid use disorder screening, evaluation, and treatment of incarcerated individuals
as provided under this section.
(j) On or before November 1, 2020, and annually thereafter, the Governor's
Office of Crime Prevention and Policy shall report data from individual local
correctional facilities to the General Assembly, in accordance with § 2-1257 of the
State Government Article, on:
(1) the number of incarcerated individuals diagnosed with:
(i) a mental health disorder;
(ii) an opioid use disorder;
(iii) a non-opioid substance use disorder; and
(iv) a dual diagnosis of mental health and substance use
disorder;
(2) the number and cost of assessments for incarcerated individuals
in local correctional facilities, including the number of unique incarcerated
individuals examined;

(3) the number of incarcerated individuals who were receiving
medication or medication-assisted treatment for opioid use disorder immediately
prior to incarceration;
(4) the type and prevalence of medication or medication-assisted
treatments for opioid use disorder provided;
(5) the number of incarcerated individuals diagnosed with opioid use
disorder;
(6) the number of incarcerated individuals for whom medication and
medication-assisted treatment for opioid use disorder was prescribed;
(7) the number of incarcerated individuals for whom medication and
medication-assisted treatment was prescribed and initiated for opioid use disorder;
(8) the number of medications and medication-assisted treatments
for opioid use disorder provided according to each type of medication and medication-
assisted treatment options;
(9) the number of incarcerated individuals who continued to receive
the same medication or medication-assisted treatment for opioid use disorder as the
incarcerated individual received prior to incarceration;
(10) the number of incarcerated individuals who received a different
medication or medication-assisted treatment for opioid use disorder compared to
what the incarcerated individual received prior to incarceration;
(11) the number of incarcerated individuals who initiated treatment
with medication or medication-assisted treatment for opioid use disorder who were
not being treated for opioid use disorder prior to incarceration;
(12) the number of incarcerated individuals who discontinued
medication or medication-assisted treatment for opioid use disorder during
incarceration;
(13) a review and summary of the percent of days, including the
average percent, median percent, mode percent, and interquartile range of percent,
for incarcerated individuals with opioid use disorder receiving medication or
medication-assisted treatment for opioid use disorder as calculated overall and
stratified by other factors, such as type of treatment received;
(14) the number of incarcerated individuals receiving medication or
medication-assisted treatment for opioid use disorder prior to release;

(15) the number of incarcerated individuals receiving medication or
medication-assisted treatment prior to release for whom the facility had made a
prerelease reentry plan;
(16) a review and summary of practices related to medication and
medication-assisted treatment for opioid use disorder for incarcerated individuals
with opioid use disorder before October 1, 2019;
(17) a review and summary of prerelease planning practices relative
to incarcerated individuals diagnosed with opioid use disorder prior to, and following,
October 1, 2019; and
(18) any other information requested by the Maryland Department of
Health related to the administration of the provisions under this section.
(k) Any behavioral health assessment, evaluation, treatment
recommendation, or course of treatment shall be reported to the Governor's Office of
Crime Prevention and Policy and also include any other data necessary to meet
reporting requirements under this section.

‹ Prev All Maryland sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.